Salus's net profit up by 26% in 2024
Ljubljana, 11 March - Salus, a Ljubljana-based pharmaceutical wholesaler, reported group net revenue of EUR 649 for 2024, up by 8.2% compared to 2023. Net profit grew by 26% to EUR 13 million, according to a financial report released on Tuesday.
The rest of this news item is available to subscribers.
The news item consists of 937 characters (without spaces) or 180 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.